Cough and Cold Products for Children
After a two-day joint meeting, the FDA Nonprescription Drugs and Pediatric Advisory Committees recommended a ban on the use of over-the-counter cough and cold products for children under six…
97 viewsAfter a two-day joint meeting, the FDA Nonprescription Drugs and Pediatric Advisory Committees recommended a ban on the use of over-the-counter cough and cold products for children under six…
97 viewsA hearing was held on the role of the Food and Drug Administration in evaluating the safety of Avandia, a drug used in the treatment of Type 2 diabetes. FDA officials testified about post-ma…
434 viewsThe House Government Reform Committee held a hearing on the Food and Drug Administration’s approval process for pharmaceutical drugs. Witnesses also talked about post-approval surveillance o…
358 viewsThis is the last day of a joint meeting of the FDA’s Arthritis and Drug Safety and Risk Management Advisory Committees. At the end of the three-day forum the 32-member panel had recommended …
140 viewsAt a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, experts discussed the safety of arthritis drugs called “COX-2” inhibitors. Dr. Anne Trontell gave…
236 viewsAt a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, members discussed the safety of drugs called “COX-2” inhibitors, such as Vioxx and Celebrex. Dr. …
290 viewsHealth care officials, pharmaceutical industry representatives, and members of the public commented on proposals by the Food and Drug Administration to approve several prescription allergy d…
564 viewsCommittee members heard testimony from medical experts on the use of chlorofluorocarbons in medical inhalers. They testified about how other propulsion methods in order to comply with the Cl…
259 views